Literature DB >> 3761957

[Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs].

P Wiedemann, K Heimann.   

Abstract

The pathogenesis of proliferative vitreoretinopathy (PVR) is divided into five stages: (1) destruction of the integrity of vitreoretinal structures; (2) cell migration; (3) cell proliferation; (4) cell contraction, and (5) stabilization by synthesis of the extracellular matrix. Current knowledge concerning the treatment of PVR with antiproliferative drugs (5-fluorouracil, Daunomycin) is described.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3761957     DOI： 10.1055/s-2008-1050715

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN： 0023-2165            Impact factor:   0.700


  7 in total

Review 1.  Strategies to influence PVR development.

Authors:  Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

2.  Cytotoxic effects of daunomycin on retinal pigment epithelium in vitro.

Authors:  M Weller; K Heimann; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

3.  Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo.

Authors:  Haihua Zheng; Zhimin Wang; Peijuan Wang; Yaqin Liu; Zhaoxin Jiang; Qianying Gao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-27       Impact factor: 3.117

4.  HLA antigens and lymphocytes in proliferative vitreoretinopathy.

Authors:  R Proença; M Carvalho; D Proença; J Verissimo; I Regadas; A Travassos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

5.  Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy.

Authors:  M Weller; K Heimann; P Wiedemann
Journal:  Int Ophthalmol       Date:  1988-01       Impact factor: 2.031

6.  The significance of fibronectin in vitreoretinal pathology. A critical evaluation.

Authors:  M Weller; P Wiedemann; K Heimann; K Zilles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

7.  Fibronectin quantification in plasma and vitreous by a noncompetitive ELISA technique.

Authors:  M Weller; P Wiedemann; K Heimann; K Zilles
Journal:  Doc Ophthalmol       Date:  1988-08       Impact factor: 2.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.